《2020 ACC/AHA心脏瓣膜病管理指南》解读

Interpretation of the 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease

《2020 ACC/AHA心脏瓣膜病管理指南》不仅在2017瓣膜病指南更新基础上对主动脉瓣狭窄、二尖瓣反流、人工心脏瓣膜、感染性心内膜炎、抗栓治疗等进行了更新,同时也涵盖主动脉瓣反流、二叶式主动脉瓣、二尖瓣狭窄、三尖瓣反流、联合瓣膜病变、妊娠合并瓣膜病、瓣膜病合并冠心病、瓣膜病合并非心脏手术以及瓣膜病综合管理前景等方面。其涵盖内容广泛,介绍详尽且全面。该文就其中的一些亮点与核心问题,包括十大要点信息、心脏瓣膜病严重程度定义以及主动脉瓣狭窄、主动脉瓣反流、二叶式主动脉瓣、二尖瓣狭窄、二尖瓣反流的管理更新进行了解读。

The 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease not only updates aortic valve stenosis,mitral regurgitation,prosthetic valves,infective endocarditis and antithrombotic treatment on the basis of the 2017 guidelines update for valvular heart disease,but also involves aortic valve regurgitation,bicuspid aortic valve,mitral stenosis,tricuspid regurgitation,combined valve disease,pregnancy with valvular disease,valve disease complicated with coronary heart disease,valve disease complicated with non-cardiac surgery and the prospect of comprehensive management of valve disease.It covers a wide range of contents,which are introduced in detail and comprehensively.This paper interprets some highlights and core issues,including the top 10 take-home messages,the severity of valvular heart disease,and the updates in the management of aortic valve stenosis,aortic valve regurgitation,bicuspid aortic valve,mitral stenosis and mitral regurgitation.